|
|
OJHAS Vol. 8, Issue 1: (2009
Jan-Mar) |
|
|
Parallel and overlapping Human Immunodeficiency Virus, Hepatitis B and C virus
Infections among pregnant women in the Federal Capital Territory, Abuja,
Nigeria |
|
Bassey EB,
Department of Medical Microbiology & Parasitology, College
of Health Sciences, University of Uyo, Nigeria, Moses, Anietie E,
Department of Medical Microbiology & Parasitology,
College of Health Sciences, University of Uyo, Nigeria, Udo, Sunde M, Department
of Medical Microbiology & Parasitology, College
of Health Sciences, University of Uyo, Nigeria, Umo, Anthony N, Department of Medical Microbiology & Parasitology, College of Health Sciences, University of Uyo, Nigeria |
|
|
|
|
|
|
|
|
|
Address For Correspondence |
Bassey EB, P.O. Box 9011, Wuse-Abuja,
Nigeria,
E-mail:
bassey69@yahoo.com |
|
|
|
|
Bassey EB, Moses AE, Udo SM, Umo AN. Parallel and overlapping Human Immunodeficiency Virus, Hepatitis B and C virus
Infections among pregnant women in the Federal Capital Territory, Abuja,
Nigeria. Online J Health Allied Scs.
2009;8(1):4 |
|
Submitted: Feb 3, 2009; Accepted: Apr
10, 2009; Published: May 5, 2009 |
|
|
|
|
|
|
|
|
Abstract: |
Background: Risk factors
that are associated with HIV infection are also associated with HBV
and HCV infections in sub-Saharan Africa. The HIV-infected pregnant
cohort represents a unique population and infection with the hepatitis
virus is considered a public health problem worldwide. Objective:
The purpose of this study was to evaluate the prevalence of Human Immunodeficiency
Virus, Hepatitis B and C virus parallel and overlapping infections among
pregnant women attending antenatal clinics in Federal Capital Territory
(FCT), Abuja. Method:
Five hundred (500) blood samples were collected from three district
hospitals in the FCT and tested at Wuse General Hospital, Abuja for
the presence of antibodies to HIV and Hepatitis C virus, and HBsAg by
ELISA technique in accordance with the manufacturer’s instructions.
HIV seropositive sera were confirmed by Western blot. Result:
Of the 500 pregnant women, those detected with HIV antibodies, HBsAg
and anti-HCV antibodies were 42 (8.4%), 19 (3.8%) and 8 (1.6%) respectively.
The overall seroprevalence of HIV and HBV or HCV co-infection was 9.5%
while 7.1% and 2.4% HIV positive pregnant women were specifically co-infected
with HBV and HCV respectively. Those within the age bracket of 15-20
years had the highest prevalence of HIV (13.4%), HBV (5.1%) and HCV
(1.9%) infections. Among the occupation characteristics of the women,
those of them involved in trading recorded the highest prevalence of
HIV (60.6%), HBV (30.3) and HCV (6.1%). HIV was higher among the married
women than the singles ((8.6% vs 6.5%); with HBV infection the reverse
was the case (3.0% vs 9.8%) while HCV was same for both groups. History
of blood transfusion did not reflect a higher rate of HIV and HBV (1.4%
vs 9.6%; 2.8% vs 4.0% respectively) unlike HCV infection with 0.5% recorded
only among those that had transfusion experience. Conclusion: When monitoring the
risk of hepatotoxicity to antiretroviral drugs among these group of
patients caution should be maintained. Moreover, evidence of parallel
and overlapping HIV, HBsAg and HCV infections among this cohort should
motivate inclusion of HBV and HCV among the diseases of surveillance
in the national sentinel survey in order to ascertain the bigger picture
of these infections in Nigeria.
Key Words: Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus,
Abuja, Nigeria
|
|
Risk factors
that are associated with HIV infection are also associated with HBV
and HCV infections in sub-Saharan Africa.(1) These include sexual behaviour,
presence of other sexually transmitted diseases, female and male circumcision
status, percutaneous and perinatal exposures, and poverty.
Hepatitis B
and C virus co-infections have been reported to be common among HIV
infected persons in various countries. In Slovenia, the overall prevalence
of HCV infection in HIV-positive persons was reported to be 16.9%. In
recent studies carried out in Northern Nigeria, the prevalence of HIV
and HCV co-infection was reported as 6.2% in Kano, Abuja 12.5% (2) and
Keffi, a neighbouring city to Abuja, 11.1%.(3) On the other hand, a
higher prevalence of 20.6% was reported among persons with HIV/HBV co-infection
in Keffi, North-Central Nigeria.(3)
Pregnant women
infected with hepatitis are very likely to transmit the infection on
to her newborn infant due to exposure to maternal blood, fluids and
faeces. About 10-20% of infants born to hepatitis B infected mothers have been
reported to be at risk of developing hepatitis.(4)
The HIV-infected
pregnant cohort represents a unique population. In the US, 6.3% was
reported as overall prevalence of HIV and hepatitis B or C virus co-infection
among pregnant women with 1.5% and 4.9% specifically co-infected with
hepatitis B and C respectively.(5) In Rwanda and Uganda, about 6% of
HIV-positive pregnant women were co-infected with either HBV or HCV.(6) In this study, we evaluate the prevalence of human immunodeficiency
virus (HIV), hepatitis B virus and hepatitis C virus among pregnant
women attending antenatal clinics in Federal Capital Territory, Abuja,
Nigeria.
Study population
This study
was conducted at the Wuse General Hospital, Abuja among pregnant women
aged between 15 and 50 years during the period of June, 2005 to March
2006
A total of
500 ante-natal attendees were recruited for the study from three district
hospitals in Abuja, comprising of Wuse (250), Nyanya (200) and Gwarinpa
(50). These hospitals are secondary health facilities that serve the
inhabitants of the Federal Capital Territory, Abuja - Nigeria.
Sample collection
Five (5) ml
of blood each was collected from subjects into plain sterile bottle
following informed consent. Blood samples were centrifuged and sera
separated and stored at -20oC until used. Samples were analyzed
in batches for antibodies to HIV-1 and 2 by ELISA (Abbot, USA) and confirmed
by Western Blot (Cambridge Biotech, UK), antibodies to Hepatitis C
by ELISA (Abbot, USA;) and HBsAg (monoclonal, ELISA; Abbot USA), in
accordance with the respective manufacturer’s instructions.
Serum samples
that were repeatedly reactive for anti- HCV and HBsAg by ELISA were
indicated as positive in the study.
Statistical
Analysis
Relative risk
at 95% Confidence Interval and test of significance at P = 0.05 using
Fisher Exact 2-tailed values were measured using Epi Info Version 6.04
statistical package
Ethical
Issues
Informed consent
and ethical approval were obtained from the subjects and authorities
of the affected district hospitals respectively.
Out of a total
of five hundred (500) samples analyzed for HIV antibodies, HBsAg and
anti-HCV antibodies, 42 (8.4%) were positive for HIV, HBsAg, 19 (3.8%)
and anti-HCV, 8 (1.6%). A break down by district hospital shows that
of the 250 samples from Wuse District Hospital, 22 (8.8%), 8 (3.2%)
and 4 (1.6%) were positive for HIV-1 antibodies, HBsAg and anti-HCV
antibodies respectively. Of the 200 samples collected from Nyanya District
Hospital, 17 (8.5%), 8 (4%) and 3 (1.5%) were positive for HIV-1, HBsAg
and anti-HCV respectively; while out of the fifty (50) samples from
Gwarinpa District Hospital, 3 (6.0%) had HIV-1 antibodies, 3 (6.0%)
and 1 (2%) were HBsAg and anti-HCV positive respectively (Table 1).
Table 1: Sample distribution
of the three district hospitals in the FCT, Abuja
Location |
No. Tested |
No. Positive (%) |
HIV |
HBV |
HCV |
Gwarinpa |
50 |
3 (6) |
3 (6) |
1 (2) |
Nyanya |
200 |
17
(8.5) |
8 (4) |
3
(1.5) |
Wuse |
250 |
22
(8.8) |
8
(3.2) |
4
(1.6) |
Total |
500 |
42
(8.4) |
19
(3.8) |
8
(1.6) |
Table 2 shows
the association and Relative Risk (95%CI) of HIV/HBV and HIV/HCV co-infections
in pregnant women attending the three District Hospitals in the FCT,
Abuja. Three (7.1%) HIV positive pregnant women were co-infected with
HBV, having relative risk of 1.95 (CI 95% 0.66–5.74) and Fisher Exact
2-tailed P=0.208 whereas only one (2.4%) pregnant woman had both HIV
and HCV co-infection (RR, 1.95 [CI 95% 0.66 – 5.74]) and Fisher Exact
2-tailed P=0.507.
Table 2:
Relative Risk (95%CI) of HIV/HBV and HIV/HCV co-infections in pregnant
women attending FCT District Hospitals
Infections |
No. positive |
Percentage |
Relative Risk (95% CI) |
P value (Fisher Exact)-2 tailed |
HIV and HBV |
3 |
7.1 |
1.95 (0.66 - 5.74) |
0.208 |
HIV and HCV |
1 |
2.4 |
1.50 (0.23
- 9.60) |
0.507 |
Table 3 indicates
age distribution of ante-natal attendees in relation to HIV, HBsAg and
anti-HCV positivity. The highest prevalence of HIV (13.4%), HBV (5.1%)
and HCV (1.9%) infections occurred in the age bracket of 21-25 years
while among the age group 15-20 years only 1.8% prevalence each was
recorded for HIV, HBV and HCV respectively. None of the pregnant women
in the age bracket 36 years and above that had HCV infection. Generally, the overall prevalence
of HBV and HCV prevalence among pregnant women in the FCT, Abuja were
3.8% and 1.6% respectively.
Majority of
the pregnant women tested were housewives, 312 (62.4%) while civil servants,
traders and students were 152 (30.4%), 33 (6.6) and 3 (0.6%) respectively
(Table 3). Findings in this study show that the highest prevalence of
HIV, HBV and HCV were recorded among Traders (60.6%, 30.3% and 6.1%
respectively) whereas students and housewives ranked second in the prevalence
of HIV (33.3%) and HBV (2.2%) respectively. Apart from HIV where civil
servants had prevalence of 5.9%, they were the least infected with HBV
(1.3%) and HCV (3.9%) compared to the other groups (Table 3).
Table
3: Age distribution of pregnant women attending Wuse, Nyanya and Gwarinpa
District Hospitals in relation to HIV, HBsAg and anti-HCV positivity
Age Range |
No. Tested |
HIV (%) |
HBV (%) |
HCV (%) |
15-20 |
55 |
1(1.8) |
1(1.8) |
1(1.8) |
21-25 |
157 |
21 (13.4) |
8 (5.1) |
3 (1.9) |
26-30 |
161 |
11 (6.8) |
6 (3.7) |
3 (1.9) |
31-35 |
104 |
8 (7.7) |
3 (2.9) |
1(1.0) |
36-40 |
17 |
0 (0.0) |
0 (0.0) |
0 (0.0) |
41-45 |
5 |
0 (0.0) |
1 (20.0) |
0 (0.0) |
46-50 |
1 |
1 (100) |
0 (0.0) |
0 (0.0) |
|
500 |
42(8.4) |
19 (3.8) |
8 (1.6) |
HIV infection
among the married were higher than the singles (8.6% vs 6.5%), whereas
the reverse was recorded for HBV infection (3.0% vs 9.8%). In the case
of HCV infection, the prevalence was the same for both groups (1.6%).
The prevalence of HIV, HBsAg and HCV among those transfused and those
never transfused is shown in Table 4. Among the pregnant women who claimed
to have received blood transfusion at one time or the other, only 1
(1.4%) was positive for HIV, HBsAg 2 (2.8%) and HCV, 6 (8.3%). However,
those that never received blood transfusion had higher prevalence of
HIV and HBV infections (9.6% and 4.0% respectively) than the transfused
except in HCV infection where prevalence was lower (0.5%).
Table
4: Demographic characteristics and
transfusion status of pregnant women attending Wuse, Nyanya and Gwarinpa
District Hospitals
Characteristics |
No. Tested |
No. Positive (%) |
HIV |
HBV |
HCV |
Occupation |
|
|
|
|
Civil servant |
152 |
9 (5.9) |
2(1.3) |
6 (3.9) |
Students |
3 |
1 (33.3) |
0 (0) |
0 (0.0) |
Housewives |
312 |
12 (3.8) |
7 (2.2) |
0(0.0) |
Traders |
33 |
20 (60.6) |
10(30.3) |
2 (6.1) |
Marital status |
|
|
|
|
Married |
439 |
38 (8.6) |
13 (3.0) |
7 (1.6) |
Single |
61 |
4 (6.5) |
6 (9.8) |
1 (1.6) |
Blood transfusion status |
|
|
|
|
Transfused |
72 |
1 (1.4) |
2 (2.8) |
6 (8.3) |
Never transfused |
428 |
41 (9.6) |
17 (4.0) |
2 (0.5) |
This study shows the prevalence
of HIV, HBV and HCV infections as well as HIV/HBV and HIV/HCV co-infections
among pregnant women attending three district hospitals in the FCT,
Abuja. The cohort of pregnant women was chosen for this study not only
because of their sexuality and vulnerability to sexually transmitted
infections but also based on the fact that the three viruses studied
share common route of transmissibility through heterosexual intercourse.
Over the years, pregnant women
cohort has been used to determine the national prevalence of HIV and
syphilis in Nigeria without concurrently surveying for HBV and HCV since
both HIV viral hepatitis share similar route of transmission.
In the recent national sentinel
survey carried in 2004 (7), HIV prevalence in the FCT, Abuja was reported
as 6.3%, whereas findings from this study shows a higher prevalence
of 8.4%. Nyanya and Wuse districts recorded HIV prevalence of 6.7% and
2.0% respectively in the 2005 sentinel report compared to 8.5% and 8.8%
respectively obtained in this study about 2 years later. Similarly,
the high prevalence of viral hepatitis (9.3%) obtained in this study
among pregnant women in Awka, Anambra State, Nigeria (8) is comparable
to 8.4% reported in this study. Abuja, being an urban city with state
of the art infrastructures has in recent times witnessed a fast population
growth as a result of increasing drift of people especially civil servants,
politicians and businessmen to the city. This mass drift is bound to
increase the level of human interactions that may inadvertently affect
disease epidemiology.
In this study, the prevalence
of HIV and HBV or HCV co-infections is recorded as 9.5% with 7.1% and
2.4% specifically co-infected with HBV and HCV respectively. This
report is higher than HIV/HBV and HIV/HCV co-infections reported in
other urban cities such as Kampala, Uganda (4.9% and 0.6% respectively)
and Kigali, Rwandan (2.4% and 4.9% respectively) (6). In Abidjan, Cote
d’Ivoire, a relatively higher frequency of HIV/HBV infection as against
HIV/HCV co-infection was recorded (9.0% and 1% respectively) (9). Apart
from incessant conflicts that may compounded the health status of some
of these African cities, it is expected that FCT, Abuja-Nigeria better
resource standing should address issues that may expose its citizenry
to the risk of acquiring HIV and/or hepatitis infections.
This study also revealed that
HIV infection possibly contributed to the incidence of HBV and HCV infections
in the FCT-Abuja where about 2-fold (7.1% vs 3.8%) and 1.5-fold (2.4%
vs 1.6%) increase in HBV and HCV infections respectively were observed
among those specifically co-infected with HIV. This observation further
implicates heterosexual intercourse in the transmission of these diseases
as earlier reported (10, 11). It is clear from this study that there
is a relatively high frequency of HIV and HBV or HCV co-infection among
this cohort where about 10% of HIV-positive women in FCT, Abuja had
a co-infection with one hepatitis virus.
Even though the influence of
parallel and overlapping infections with HIV on vertical transmission
of HBV and HCV in pregnant women is not clear, other workers have speculated
hepatitis virus may act as cofactor for HIV disease progression (2)
In this study, infection with the three viruses was one of the highest
among those in the age bracket 21-25 years. This age group falls among
the sexually active age groups in Nigeria and the result further confirms
the fact that the infections are prevalent by sexual contact as earlier
reported (10).
Assessing occupational risk
in acquiring the infections, this study indicates that women who are
traders suffered the highest rates with HIV, HBV and HCV. This could
be explained by the fact that some of the market women do travel long
distances away from their spouses and may stay many days before return
and may have been involved in illicit unprotected sex that may lead
to sexual transmitted diseases. It’s not uncommon that Abuja situated
in North Central Nigeria, market women may travel down up to the coastal
and far northern states to acquire market wares thereby prolonging their
period of stay away from home.
Results of this study also
revealed a high prevalence of HCV recorded among pregnant women that
had recently received blood transfusion. This emphasizes the need to
include the routine screening of HCV along wit HIV and HBV in the current
safe blood practices in all hospitals. It is common knowledge that in
Nigeria, screening of blood donors in most hospitals is done for HIV
alone and in some cases with HBV.
In conclusion,
findings from this study have raised pertinent issues of public health
importance particularly the high prevalence of parallel and overlapping
HIV, HBV HCV infections found among pregnant women in the FCT-Abuja,
Nigeria. Hence, when monitoring the risk of hepatotoxicity to antiretroviral
drugs among these group of patients caution should be maintained. Also,
there is need to include HBV and HCV among the disease of surveillance
in the biannual national sentinel survey.
- Mboto CI, Davies
A, Fielder M, Jewell AP. Human
Immunodeficiency virus and hepatitis C co-infection in sub-Saharan West
Africa. British
Journal of Biomedical Sci 2006:63 1):29-37.
- Emokpae MA, Nwokedi
EE, Jegede EE. Impact of Hepatitis C Co-Infection on CD4 Cell Count
in HIV Infected Subjects. Online J Health Allied Scs.
2008;7(2):3
- Forbi JC, Gabadi
S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, Agwale SM. The role of triple infection with hepatitis B virus, hepatitis
C virus and human immunodeficiency virus (HIV) type 1 on CD4+ lymphocytes
levels in highly infected population of North Central, Nigeria. Mem. Inst. Oswaldo Cruz
2007;102(4):535-537.
- Alvarez-Muñoz
MT, Vázquez-Rosales JG, Torres-López
FJ et al. Infection
of pregnant women with hepatitis B and C viruses and risks for vertical
transmission. Autumn 1997;28(3):415-9
- Santiago-Munoz Patricia,
Roberts Scott, Sheffield Jeanne, Mcelwee Barbara, Wendel George D.
Prevalence of hepatitis B and C in pregnant women who are infected with
human immunodeficiency virus. Am J. Obstet Gynecol
2008;193(3):1270-1273
- Pirillo Maria F; Bassani Luciana; Germinario Elena A P et al.
Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
Journal of medical virology 2007;79(12):1797-801
- FMOH. Technical
Report Nigeria National HIV/Syphilis Sero-Prevalence Sentinel Survey. 2005
- Ezegbudo CN, Agbonlahor
DE, Nwobu GO, Igwe US, Agab MI, Okpala HO. The Seroprevalence of
hepatitis B surface antigen and human immunodeficiency virus among pregnant
women in Anambra State, Nigeria. Shiraz e-Medical Journal April 2004;5(2):215-219
- Rouet, François,
Marie-Laure Chaix, André Inwoley et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative
pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236
Study Journal of Medical Virology 2004;74:34-40.
- Simpore, Jacques,
Aly Savadogo, Denise Ilboudo et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection
among HIV-positive and negative pregnant women in Burkina Faso J.
Med. Virol. 2006;78:730-733,
- Moges Feleke,
Yenew Kebede, Afework Kassu et al. Seroprevalence of HIV,
Hepatitis B infections and syphilis among street dwellers in Gondar
city, Northwest Ethiopia Ethiop.J.Health
Dev. 2006'20(3):160-165
.
|